Description of the Incident of Fever and Local Pain Following Pentabio Immunization in Infants at the Integrated Health Post (Posyandu) at the Timpah Community Health Center, Central Kalimantan
DOI:
https://doi.org/10.57214/jasira.v3i2.322Keywords:
Adverse Events, Fever, Infant, Immunization, Local PainAbstract
Immunization is a vital public health strategy to prevent infectious diseases and reduce morbidity and mortality. In Indonesia, the Pentabio vaccine protects against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b. Despite its effectiveness, post-immunization reactions such as fever and local pain are common, potentially affecting caregiver perceptions and immunization adherence. A descriptive observational study with a cross-sectional design was conducted among infants receiving Pentabio immunization at Posyandu in the UPT Timpah Community Health Center, Central Kalimantan. Data were collected through structured observation and caregiver interviews for infants aged 2–11 months. Fever (≥37.5°C) and local pain (tenderness, redness, or swelling) were assessed. Of the 30 infants, 40% were aged 2–3 months, 33.33% were 4–6 months, and 26.67% were 7–11 months, with slightly more males (53.33%). Post-immunization fever occurred in 60%, and local pain in 70%, with both reactions being mild, transient, and appearing within 24–48 hours. These findings highlight the commonality of mild adverse events, especially in early infancy, and underscore the need for clear caregiver education to maintain confidence in immunization services and ensure adherence to vaccination schedules.
References
Aherkar, R. Y., Deshpande, P. K., & Ghongane, B. B. (2021). Epidemiological study of adverse events following immunization in children under 5 years. Journal of Family Medicine and Primary Care, 10(7). https://doi.org/10.4103/jfmpc.jfmpc_1582_21
Flanagan, K. L., Fink, A. L., Plebanski, M., & Klein, S. L. (2017). Sex and gender differences in the outcomes of vaccination over the life course. Annual Review of Cell and Developmental Biology, 33, 577–599. https://doi.org/10.1146/annurev-cellbio-100616-060530
Hervé, C., Laupèze, B., Del Giudice, G., Didierlaurent, A. M., & Tavares Da Silva, F. (2019). The how’s and what’s of vaccine reactogenicity. NPJ Vaccines, 4(1), 39. https://doi.org/10.1038/s41541-019-0092-6
Hidayati, C., Wati, D. P., & Nurhidayah, L. (2020). Adverse events following immunization (AEFI) profile of Pentabio vaccine in infants: A community-based cross-sectional study. Journal of Preventive Medicine and Public Health, 53(4), 289–296. https://doi.org/10.3961/jpmph.20.131
Kementerian Kesehatan RI. (2020). Pedoman imunisasi dasar lengkap. Kementerian Kesehatan RI.
Klein, S. L., & Flanagan, K. L. (2016). Sex differences in immune responses. Nature Reviews Immunology, 16(10), 626–638. https://doi.org/10.1038/nri.2016.90
Mittal, S., Rawat, C., Gupta, A., Solanki, H. K., & Singh, R. K. (2023). Adverse events following immunization among children under two years of age: A prospective observational study from North India. Cureus, 15(4), e38356. https://doi.org/10.7759/cureus.38356
Owais, A., Hameed, A., & Siddiqui, A. (2020). Side effects and safety profile of pentavalent vaccine among infants: A community-based survey. Vaccine Development and Therapy, 10, 11–20. https://doi.org/10.2147/vdt.s323485
Pan, X., Hu, Y., Chen, F., Lv, H., Wang, Y., & Liang, H. (2021). Analysis of adverse events following immunization in Zhejiang, China: A retrospective cross-sectional study based on the passive surveillance system. Human Vaccines & Immunotherapeutics, 17(10), 3823–3830. https://doi.org/10.1080/21645515.2021.1924650
Pan, X., Lv, H., Liang, H., Wang, Y., Shen, L., Chen, F., & Hu, Y. (2022). Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China. Human Vaccines & Immunotherapeutics, 18(1), 2021711. https://doi.org/10.1080/21645515.2021.2021711
Pulendran, B., Li, S., & Nakaya, H. I. (2021). Systems vaccinology. Immunity, 53(6), 887–905. https://doi.org/10.1016/j.immuni.2020.11.004
Restu, N. K., Sari, R. M., & Prasetyo, D. (2021). Factors influencing early immunization uptake: Evidence from rural community health posts. Global Health Research and Policy, 6(23). https://doi.org/10.1186/s41256-021-00226-7
Sari, D. R., Hamid, A. R., & Utami, D. S. (2019). Post-immunization reactions of Pentabio vaccine in infants at community health centers in Indonesia. Indonesian Journal of Child Health, 7(3), 112–120. https://doi.org/10.24235/ijch.v7i3.1250
Sharma, R., Sharma, B., Saini, Y., Bairwa, R., & Kakkar, M. (2025). Adverse events following pentavalent vaccine administration: A descriptive study in the Indian context. Journal of Berk Epidemiology, 13(2), 112–117. https://doi.org/10.1169/jbe.2025.0211
Siegrist, C. (2018). Vaccine immunology. In Vaccine (7th ed., pp. 16–34). Elsevier. https://doi.org/10.1016/B978-0-323-46900-6.00002-5
Sundoro, J., Prayitno, A., Satari, H. I., Djelantik, I. G., Fletcher, M. A., & Hadinegoro, S. R. (2024). Safety of a 2-dose primary series of 13-valent pneumococcal conjugate vaccine in Indonesian infants. Medical Journal of Indonesia.
World Health Organization (WHO). (2019). WHO vaccine safety basics training: Module 2 – How vaccines work [Internet]. WHO Press. Available from:
World Health Organization (WHO). (2020). Immunization in practice: A practical resource guide for health staff (4th ed.). WHO Press.
Wulandari, Y., Putri, A. M., & Firdaus, E. (2022). Incidence and management of common adverse events following Pentabio immunization in infants. Journal of Tropical Plant Science, 68(2). https://doi.org/10.20886/jtps.2022.68.2.1002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Siti Rufaidah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
